AI For Pharma Growth

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Francois Gand, Founder and CEO of NURO.   Francois shares his inspiring personal journey that led him to create NURO, a non-invasive brain-computer interface. After experiencing tragedies with his family members' health issues and his own accident, Francois was motivated to develop technologies allowing people to communicate reg...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Dr. Florian Wolf, Founder and CEO of Mergeflow.   Dr. Wolf shares the evolutionary journey of Mergeflow, highlighting how it transformed from a retrieval system into an AI research assistant. The platform's core functions involve meticulous information gathering, relying on a robust infrastructure. Global patterns and R&D publi...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Steve Raju, the Founder of License to Quill.   Steve has a strong interest in marketing, persuasion, and influence, and speaks about how to effectively utilise GPT text models. He explains the overlaps of technology and marketing and the opportunities for companies to use GPT & Large Language Models to improve their workflows. ...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Omi Bell to explore women's diversity and its impact on clinical trials, along with the transformative role of AI in addressing related challenges.   Omi highlights the concerning gender & racial disparity in the pharmaceutical industry. She shares her inspiring story of building her successful business and speaks about the hur...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Steve Anderson, author of The Bezos Letters, to discuss the 14 principles for growth that Pharma can learn from Amazon.   Steve emphasises that the biggest risk businesses face is not taking enough risk. Steve highlights the concept of innovation being a byproduct of inventing something new and elaborates on how Amazon applies...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Alex Fink, founder of Otherweb, to discuss the topic of fake data AI and how to deal with it.   They explore how AI differs from fake news and other forms of misinformation and Alex emphasises that the biggest problem facing humanity today is the abundance of junk information. Alex explains the need for fake news detectors amid...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Patrick de Boer, Founder of Peak Data.   Dr Bates and Patrick speak on the ways in which AI can greatly enhance productivity and efficiency in the pharmaceutical industry. Patrick talks about the importance of having a comprehensive list of key opinion leaders and the challenges posed by their absence. He provides insights into...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Bruno Pešec, who shares his journey into the pharmaceutical industry.   They explore the distinction between doing and managing innovation, emphasising the pitfalls to avoid. Bruno highlights the significance of investing wisely, steering clear of ideas with limited market potential. Overcoming executive fear of innovation and...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philippe Chambadal from Wand. AI.   Philippe discusses the challenge of scaling AI in the enterprise space and working with large language models and predictive analytics. Philippe explains that AI can be applied across different sectors, such as finance, forecasting, supply chain analysis, manufacturing, quality control, and p...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Jessica Gibson, the CEO and co-founder of Ariel Precision Medicine, a vertically integrated precision medicine company.   Jessica shares her journey, discussing how she got started in the field and her passion for personalised patient care. She shares the vision and mission of Ariel Precision Medicine, with a particular focus o...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Burak Akicier and Prof. Arzu Kanik to discuss medical research support programs for medical and clinical researchers.   Arzu & Burak share how they got started with e-Picos and explain the significance of writing results at the end of a manuscript review before publishing.   e-Picos caters to all researchers and uses AI to help...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Bethany Corbin, founder of FemInnovation, to discuss the intersection of AI in FemTech and women's health.   Bethany explains the four pillars of FemInnovation and the importance of bridging the gap between tech founders and clinicians. Dr. Bates & Bethany speak about women's health within the broader context of digital health....

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Pamela Bush, Chief Business Officer at Predictive Oncology.   Pamela shares her journey into the life sciences and how she established her own consulting firm. She delves into the evolution of predictive oncology and its role in bridging the gap between scientists and non-scientists.   Pamela explains how predictive oncology ut...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Frank Mendoza, founder of Catalytics.   They explore the risks associated with large language models and the advancement of generative AI, which is rapidly progressing logarithmically. Mendoza emphasises how AI is levelling the playing field and discusses the biggest opportunities for generative AI, particularly in patient enga...

In this episode of AI For Pharma Growth, Dr Andree Bates talks about AI and its implications for the pharmaceutical industry.   She explores AI's role in content creation, she challenges assumptions about its superiority amidst fears of human laziness and incompetence. Dr. Bates addresses concerns over evil AI's and the importance of responsible strategies and governance frameworks. The accessibil...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Dr. Tim Hindmarsh, a board-certified physician currently practising urgent care.   Dr Bates & Dr Hindmarsh discuss the future of AI and its impact on healthcare. With the rapid advances in technology, AI is becoming more integrated into medical practices, leading to improved patient care and outcomes. Dr. Hindmarsh shares his i...

In this episode of AI for Pharma Growth, Dr. Andree Bates is joined by James Jordan, a medical futurist and innovation expert.   They discuss James’s background and predictions for healthcare AI and technology. James shares his top 10 healthcare predictions for the next three to five years, including the increasing use of telemedicine and AI in precision medicine. James talks about the use of AI i...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Matt Foster, CEO and Co-Founder of Concr, a company that is making strides in solving data challenges in oncology using AI.   Over 90% of novel cancer drugs fail early in clinical trials, leading to an increasing amount of data being generated. However, this data will only hold limited value unless it can be interlinked to gener...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Raj Vaghela, CEO of PubHive, a company leveraging AI to automate drug safety and pharmacovigilance processes.   Pharmacovigilance professionals now face a significantly increased workload to evaluate this high volume of data. AI-powered technologies can help alleviate this burden, while ensuring a more precise and systematic eva...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Calum Chace to discuss a wide range of topics including philosophy, autonomous cars, drug development costs, and the current state of the healthcare industry. They explore the potential unintended consequences of technological advancements such as the arrival of technological unemployment and AI safety concerns. Calum explains...

In this episode of AI For Pharma Growth, Dr Andree Bates talks to Dr Harshit Jain, founder of Doceree, which leverages AI within programmatic marketing to HCPs.   Dr Jain noticed the online content aimed at physicians was incredibly static compared to content aimed at traditional consumers. As a result, he founded Doceree to engage with physicians on digital in a measurable, organic, and transpare...

In this episode of AI for Pharma Growth, Dr. Andree Bates shares insights into using a machine learning algorithm for pricing.   Dr Bates speaks about artificial intelligence and its growing impact in the healthcare industry. AI can be leveraged in a variety of ways to help people, and the world is rapidly changing as a result of these technological advancements.   She explains how the integration...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patricia Gill, the founder of SAMHI, the Swiss Association for Mental Health Innovation, which is supporting AI and tech solutions for mental health, with a main goal of bringing relevant deep tech, mental health solutions to the market.   They discuss how tech and AI are advancing mental health innovation and how mental health...

In this episode of AI For Pharma Growth, Dr Andree Bates talks about the ways in which AI has transformed the pharmaceutical industry.   AI is already being used across the pharmaceutical industry, from use in clinical trials to improve the accuracy and speed of drug development, to identifying patients with rare diseases who might benefit from targeted therapies. There are also programmes being d...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Clemens Behrend, the founder of Web3CX, which designs Web3 customer experience solutions.   They discuss how to use artificial intelligence to make your customer experience more personalised and impactful. Customer experience is the internal and subjective response people have to any direct or indirect contact with a company.  ...